CLINITECH LABORATORY LIMITED (CTLLAB) boosts its diagnostic capabilities with the launch of an in-house molecular department.

This significant operational upgrade enables CTLLAB to perform all molecular tests internally, directly addressing patient medical needs.

The move enhances the company's service offerings and operational efficiency, positioning it to improve patient care and potentially capture more diagnostic volume, a key development for shareholders.